基于布普伦诺芬 (纳洛) 的阿片类抗体维持治疗6个月后的神经认知功能:一项受控前性研究
Abhishek Ghosh1, Alka Shaktan1, Ritu Nehra2
1From the Drug Deaddiction and Treatment Centre, Department of Psychiatry.
Journal of clinical psychopharmacology
|February 29, 2024
概括
布普伦诺芬治疗显著改善了阿片类药物使用障碍 (OUD) 患者的认知功能. 在多个测试中观察到神经认知的这些收益,并不是由于实践效应或其他混因素.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿片类药物使用障碍 (OUD) 可以影响神经认知功能.
- 目前对OUD药物和认知的研究受限于功率,混因素和实践效应.
- 布普伦诺芬 (纳洛) 是OUD治疗的一个关键药物.
研究的目的:
- 为了检查6个月布普伦诺芬治疗后OUD患者的认知功能变化.
- 为了比较布普伦诺芬治疗的OUD患者和对照组之间的认知表现.
主要方法:
- 招募了498名OUD患者开始服用布普伦诺芬;199人完成了6个月的随访.
- 在基线和6个月后进行的神经认知评估.
- 包括威斯康星州卡片排序测试,爱荷华州博任务,步道制作测试和N-Back测试;对混者进行控制.
主要成果:
- 在布普伦诺芬治疗6个月后,32个认知参数中的25个显著改善.
- 在执行功能,处理速度和工作记忆领域中注意到了改进.
- 被治疗的OUD患者在治疗后表现出比对照组更好的认知表现.
结论:
- 布普伦诺芬治疗导致OUD患者的认知能力显著改善.
- 观察到的认知收益是强大的,不能归因于实践效应或混变量.
- 这些发现支持布普伦诺芬在恢复OUD中神经认知功能方面的作用.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
295
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
295
Analgesia and Pain Management
618
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
618
Drug Dependence
1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K
Drug Abuse and Addiction: Pharmacological Phenomena
472
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
472
CNS Depressants: Alcohol and Nicotine
207
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
207
Opioid Receptors: Overview
808
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
808


